Breaking News

Ergomed Acquires MedSource

Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.

By: Contract Pharma

Contract Pharma Staff

Ergomed plc, a company focused on providing specialized services to the pharmaceutical industry, has acquired MS Clinical Services, LLC (MedSource), a specialized CRO based in Houston, TX, for an initial consideration of $16.2 million in cash at closing, up to $1.8 million in Ergomed shares, and up to a further $7.0 million depending on MedSource’s financial results FY21. MedSource is a full-service CRO with a focus on complex diseases and study designs, specializing in oncology and rare dis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters